Oxytocin’s social and stress-regulatory effects in children with autism and intellectual disability: a protocol for a randomized placebo-controlled trial

Oxytocin’s social and stress-regulatory effects in children with autism and intellectual disability: a protocol for a randomized placebo-controlled trial

Abstract Background Oxytocin is increasingly considered as a new pharmacological option for mitigating social difficulties and regulating stress in autism spectrum disorder. However, in prior trials, autistic individuals with co-occurring intellectual disability (ID) have largely been overlooked, de...

Full description

Bibliographic Details
Main Authors: G. Ricchiuti, A. Taillieu, E. Tuerlinckx, J. Prinsen, E. Debbaut, J. Steyaert, B. Boets, Kaat Alaerts
Format: Article
Language:English
Published: BMC 2025-03-01
Series:BMC Psychiatry
Subjects:
Oxytocin
Children
Autism
Intellectual disability
Clinical trial
Online Access:https://doi.org/10.1186/s12888-025-06617-6

Internet

https://doi.org/10.1186/s12888-025-06617-6

Similar Items